Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. | 875,000 | reported | 11 Dec 2025 | tx 1+875,000 |
| BELLICUM PHARMACEUTICALS, INC | 400,000 | reported | 15 Aug 2022 | tx 13+4,088,000 |
| Clovis Oncology, Inc. | 42,223 | reported | 10 Jun 2021 | tx 4+137,091 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Dec 2025 | GRANT_AWARD | Enliven Therapeutics, Inc. | 875,000 | 0.00 USD | deriv |
| 15 Aug 2022 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 400,000 | 1.44 USD | deriv |
| 16 Aug 2021 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 265,000 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Clovis Oncology, Inc. | 42,223 | 0.00 USD | deriv |
| 15 Dec 2020 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 286,000 | 0.00 USD | deriv |
| 04 Jun 2020 | GRANT_AWARD | Clovis Oncology, Inc. | 40,138 | 0.00 USD | deriv |
| 17 Mar 2020 | PURCHASE | BELLICUM PHARMACEUTICALS, INC | 5,000 | 4.00 USD | |
| 03 Feb 2020 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 1,257,000 | 0.00 USD | deriv |
| 10 Sept 2019 | PURCHASE | BELLICUM PHARMACEUTICALS, INC | 40,000 | 1.25 USD | |
| 21 Aug 2019 | PURCHASE | BELLICUM PHARMACEUTICALS, INC | 20,000 | 0.99 USD | |
| 11 Jun 2019 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 300,000 | 0.00 USD | deriv |
| 06 Jun 2019 | GRANT_AWARD | Clovis Oncology, Inc. | 28,882 | 0.00 USD | deriv |
| 01 Feb 2019 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 300,000 | 0.00 USD | deriv |
| 11 Oct 2018 | GRANT_AWARD | Clovis Oncology, Inc. | 25,848 | 0.00 USD | deriv |
| 02 Jul 2018 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 225,000 | 0.00 USD | deriv |
| 02 Jan 2018 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 225,000 | 0.00 USD | deriv |
| 30 Jan 2017 | GRANT_AWARD | BELLICUM PHARMACEUTICALS, INC | 500,000 | 0.00 USD | deriv |